Return to Statistics Toolbox

Pathway mapping for Study ST000381

(Analysis All analyses used)
Select one or more experimental factors for Groups 1 and 2. The members of each group should be DIFFERENT.
Group1Experimental factorGroup2
Cohort:CSMC | Treatment:ICPBS Urine-IC12 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC14 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC19 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC20 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC21 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC22 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC30 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC31 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC32 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC48 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC52 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC53 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC5 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:ICPBS Urine-IC9 | SubCondition:SEVERE (1)
Cohort:CSMC | Treatment:Matched control-C10 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C13 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C15 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C16 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C17 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C18 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C26 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C27 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C28 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C33 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C40 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C45 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C49 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C50 | SubCondition:n/a (1)
Cohort:CSMC | Treatment:Matched control-C51 | SubCondition:n/a (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 10 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 11 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 12 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 13 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 14 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 15 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 16 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 17 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 18 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 19 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 1 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 20 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 21 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 22 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 24 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 25 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 26 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 27 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 28 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 29 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 2 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 30 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 31 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 32 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 33 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 34 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 35 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 36 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 37 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 38 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 39 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 3 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 40 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 41 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 42 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 43 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 4 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 5 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 6 | SubCondition:SEVERE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 7 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 8 | SubCondition:INTERMEDIATE (1)
Cohort:INHA | Treatment:ICPBS Urine-IC 9 | SubCondition:MODEST (1)
Cohort:INHA | Treatment:Matched control-C 10 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 11 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 12 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 13 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 14 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 15 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 16 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 17 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 18 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 19 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 1 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 20 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 21 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 2 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 3 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 4 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 5 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 6 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 7 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 8 | SubCondition:n/a (1)
Cohort:INHA | Treatment:Matched control-C 9 | SubCondition:n/a (1)
Limit by pathway class:
Analysis:Combine data for all analyses?:     

  logo